Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
covid-19 t memory cells and nk cells (1 trial)
Coronavirus Infections (Phase 2)
Lymphopenia (Phase 2)
Pneumonia (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)